Effectiveness of Drug-eluting Stent listed as Co-payment service by National Health Insurance
碩士 === 高雄醫學大學 === 醫務管理學研究所碩士在職專班 === 96 === Background According to report from Natinal Department of Health, coronary artery disease (CAD) was the 2nd in top of ten death causes during 2007 in Taiwan. The National Health Insurance Bureau started the co-payment method so that those patients indicat...
Main Authors: | Shu-Hui Kuo, 郭淑惠 |
---|---|
Other Authors: | Herng-Chia Chiu |
Format: | Others |
Language: | zh-TW |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/70845432577527877515 |
Similar Items
-
Factors Associated with The Price of Drug-eluting Stents under Balance Billing Payments
by: Yu-Chi Hung, et al.
Published: (2009) -
Drug-eluting stent in diabetes
by: Hernani Pinto de Lemos Júnior, et al. -
Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
by: Negar Faramarzi, et al.
Published: (2015-10-01) -
The Knowledge, Attitude, and Behavior of Health Services Consumers and Providers under National Health Insurance Outpatient Drug Co-payment Program in Taiwan.
by: Lin, Hui-Wen, et al.
Published: (2001) -
Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)